Glass House Brands (GLAS) Accounts Payables (2020 - 2026)
Glass House Brands (GLAS) posted quarterly Accounts Payables of $38.1 million for Q1 2026, up 23.96% year-over-year from $30.7 million in Q1 2025, and up 5.83% quarter-over-quarter from $36.0 million in Q4 2025.
Glass House Brands (GLAS) Accounts Payables (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Accounts Payables for 7 consecutive years, with $38.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables rose 23.96% year-over-year to $38.1 million; the TTM figure through Mar 2026 stood at $38.1 million (up 23.96% YoY), while the FY2025 annual figure was $36.0 million, up 15.56% from the prior year.
- Accounts Payables improved to $38.1 million in Q1 2026 per GLAS's latest filing, from $36.0 million in the prior quarter.
- Across five years, Accounts Payables topped out at $38.1 million in Q1 2026 and bottomed at $7.3 million in Q1 2022.
- Historically, Accounts Payables has averaged $27.6 million across 5 years, with a median of $28.8 million in 2025.
- Annual changes were most pronounced in 2022 — Accounts Payables slumped 56.96% — and 2023, when it jumped 236.48%.
- Glass House Brands' Accounts Payables stood at $22.0 million in 2022, then rose by 22.59% to $26.9 million in 2023, then grew by 15.58% to $31.1 million in 2024, then gained by 15.56% to $36.0 million in 2025, then gained by 5.83% to $38.1 million in 2026.
- Business Quant data shows GLAS's Accounts Payables at $38.1 million in Q1 2026, $36.0 million in Q4 2025, and $28.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 356.00 Mn |
| 10 | Glass House Brands | 837.25 Mn | 818.69 Mn | 15.77 Mn | 38.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.07 Mn |
| Dec 31, 2025 | 35.97 Mn |
| Sep 30, 2025 | 28.76 Mn |
| Jun 30, 2025 | 37.53 Mn |
| Mar 31, 2025 | 30.71 Mn |
| Dec 31, 2024 | 31.13 Mn |
| Sep 30, 2024 | 32.75 Mn |
| Jun 30, 2024 | 33.74 Mn |
| Mar 31, 2024 | 29.77 Mn |
| Dec 31, 2023 | 26.93 Mn |
| Sep 30, 2023 | 27.74 Mn |
| Jun 30, 2023 | 28.03 Mn |
| Mar 31, 2023 | 24.63 Mn |
| Dec 31, 2022 | 21.97 Mn |
| Sep 30, 2022 | 23.01 Mn |
| Jun 30, 2022 | 11.92 Mn |
| Mar 31, 2022 | 7.32 Mn |
| Dec 31, 2021 | 9.94 Mn |
| Sep 30, 2021 | 18.03 Mn |
| Jun 30, 2021 | 19.60 Mn |